Press Release: GFBiochemicals Starts Production Of Levulinic Acid

gfbioBiobased chemical company GFBiochemicals has started commercial production at its 10,000 MT/a capacity levulinic acid plant in Caserta, Italy.  The announcement was made at the BIO World Congress on Industrial Biotechnology, Montreal.  GFBiochemicals is the first company to produce levulinic acid at commercial scale directly from biomass.

"Caserta is now the world's largest operational production plant for levulinic acid," said Chief Commercial Officer Marcel van Berkel.  "A fundamentally lower price range is now possible using our unique technology.  This will give access to previously undiscovered market segments."

CEO Maxim Katinov said, "GFBiochemicals has successfully achieved a substantial milestone – the start-up of commercial-scale production.  I would like to praise and thank our engineering and R&D teams who have clearly demonstrated the company's ability to deliver results on schedule."

About GFBiochemicals
Founded in 2008, GFBiochemicals uses breakthrough technology to commercialize levulinic acid – a valuable biobased building block for specialty chemicals and materials.  With offices in Milan, Italy and Geleen, the Netherlands, its commercial-scale production plant is based in Caserta, Italy.  Personnel have decades of proven experience in innovation, production and business development of biobased chemicals.

For more information and a sample of levulinic acid visit

Media Contact
Kathryn Sheridan
Sustainability Consult
This email address is being protected from spambots. You need JavaScript enabled to view it.
Europe: +32 496 116198
North America: (202) 470 3239

Brand Perspectives
On Biomaterials


Download Now